These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8968468)

  • 1. Oral bromhexine has no effect on tear secretion in healthy subjects.
    Avisar R; Robinson A; Savir H; Levinsky H
    Ann Pharmacother; 1996 Dec; 30(12):1498. PubMed ID: 8968468
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral bromhexine has no effect on tear and lysosyme secretion in healthy subjects.
    Avisar R; Robinson A; Savir H; Levinsky H
    Metab Pediatr Syst Ophthalmol (1985); 1996-1997; 19-20():37-9. PubMed ID: 11548784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental studies on the influence of selected preparations on secretion of tear fluid. I. Schirmer test I and lysozyme test].
    Oleszczyńska-Prost E
    Klin Oczna; 1994 Jan; 96(1):5-7. PubMed ID: 7915765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental studies on the influence of selected preparations on secretion of tear fluid. II: Light and transmission electron microscopy].
    Oleszczyńska-Prost E
    Klin Oczna; 1994 Jan; 96(1):8-11. PubMed ID: 7915766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromhexine elevates REP2 expression to stimulate secretion from human primary conjunctiva fornix epithelial cells.
    Wang L; Yu L; Li N; Wang Y; Yang M; Peng Y; Guo H; Ye L
    FEBS Lett; 2020 Jan; 594(1):153-160. PubMed ID: 31365127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of ambroxol and bromhexine as mucolytics for enhanced diffusion of furaltadone into tracheobronchial secretions in broilers.
    Sumano H; Gracia I; Capistrán A; Meade G; Rivero A; Ruiz-Ramírez L
    Br Poult Sci; 1995 Jul; 36(3):503-7. PubMed ID: 7583380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antioxidative activity of the mucoregulatory agents: ambroxol, bromhexine and N-acetyl-L-cysteine. A pulse radiolysis study.
    Felix K; Pairet M; Zimmermann R
    Life Sci; 1996; 59(14):1141-7. PubMed ID: 8831801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bromhexine on the secretions of saliva and tears.
    Misawa M; Ohmori S; Yanaura S
    Jpn J Pharmacol; 1985 Oct; 39(2):241-50. PubMed ID: 4087569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of bromhexine and ambroxol, semi-synthetic derivatives of vasicine from the Indian shrub Adhatoda vasica, against Mycobacterium tuberculosis in vitro.
    Grange JM; Snell NJ
    J Ethnopharmacol; 1996 Jan; 50(1):49-53. PubMed ID: 8778507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the effect of repeated peroral administration of 3 mucolytic agents on the ultrastructure of the epithelium in the respiratory tract].
    Konrádová V; Vávrová V; Sulová J
    Cesk Pediatr; 1985 Oct; 40(10):565-8. PubMed ID: 3933839
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative histochemical study of the mechanism of action of 2 synthetic mucolytic agents, NA 872 and NA 274].
    Pesce Delfino V; Ricco R
    Pathologica; 1981; 73(1027):785-91. PubMed ID: 7342034
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trial of bromhexine in Sjögren's syndrome.
    Avisar R; Savir H; Machtey I; Ovaknin L; Shaked P; Menache R; Allalouf D
    Ann Ophthalmol; 1981 Aug; 13(8):971-3. PubMed ID: 7027873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of bromhexine as a treatment regimen in Sjögren's syndrome-like disease in the NOD (non-obese diabetic) mouse.
    Nanni JM; Nguyen KH; Alford CE; Robinson CP; Stewart CM; Maeda N; Humphreys-Beher MG
    Clin Exp Rheumatol; 1997; 15(5):515-21. PubMed ID: 9307859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of bromhexine hydrochloride and S-carboxymethyl-L-cysteine on guinea-pig uterine microflora.
    Malhi JS; Gard PR; Hanlon GW; Marriott C
    J Pharm Pharmacol; 1987 Dec; 39(12):1025-8. PubMed ID: 2894430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucolytic agents and mucociliary activity.
    Gunnarsson M; Hybbinette JC; Mercke U
    Rhinology; 1984 Dec; 22(4):223-31. PubMed ID: 6151739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sputum and expectorants].
    Korsgaard B; Pedersen JT
    Ugeskr Laeger; 1976 Sep; 138(39):2355-61. PubMed ID: 9719
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antitussives and expectorants-a review (author's transl)].
    Petrin A; Schmidt R
    Schweiz Rundsch Med Prax; 1974 Jan; 63(2):30-6. PubMed ID: 4605508
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of expectorants on relaxation behavior of sputum viscoelasticity in vivo.
    Shimura S; Okubo T; Maeda S; Aoki T; Tomioka M; Shindo Y; Takishima T; Umeya K
    Biorheology; 1983; 20(5):677-83. PubMed ID: 6375756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kinetics of mucus].
    Bury T; Corhay JL; Radermecker MF
    Rev Med Liege; 1990 Jan; 45(1):29-33. PubMed ID: 2305139
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential modulation of IgE-dependent activation of human basophils by ambroxol and related secretolytic analogues.
    Gibbs BF
    Int J Immunopathol Pharmacol; 2009; 22(4):919-27. PubMed ID: 20074455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.